Lannett expands strategic relationship with HEC for biosimilar AspartLannett and HEC will co-develop biosimilar insulin Aspart, with Lannett possessing exclusive U.S. commercialization rights. Lannett intros generic ThorazineThorazine had a market value of approximately $120 million for the 12 months ended November 2020, according to IQVIA, although actual generic market values are expected to be lower. Hikma intros ephedrine sulfate Ephedrine sulfate injection had a market value of approximately $64 million in the 12 months ended November 2020, according to IQVIA. Unichem gets FDA OK for generic Celebrex Unichem's generic Celebrex will be available in four dosage strengths: 50 mg, 100 mg, 200 mg, and 400 mg. Sandoz, Slayback Pharma partner to launch generic Firazyr Sandoz has signed a U.S. commercialization deal with Slayback Pharma to launch generic Firazyr (icatibant injection). What’s in store: Pharmacy execs size up the industry in the wake of 2020 Drug Store News reached out to a number of key industry executives to get their sense of how the pharmacy industry managed in 2020. ANI launches prazosin capsules Prazosin capsules had a market value of approximately $46.2 million, according to IQVIA. Dr. Reddy's intros generic Sabril The Sabril brand and generic had a market value of approximately $141 million for the most recent 12 months ending in December 2020, according to IQVIA. Glenmark obtains FDA nod for generic Evekeo Evekeo tablets had a market value of approximately $21.5 million for the 12-month period ended November 2020, according to IQVIA. Unichem gets FDA nod for generic Zonegran Unichem's generic Zonegran provides a treatment for partial seizures in adult patients with epilepsy. First Previous 127 128 129 130 131 Next Last
